Phoenix Biotech Acquisition Corp. filed a Form 8-K to announce the approval of a Charter Amendment to extend the business combination deadline and provide the board of directors the ability to further extend the deadline. Holders of 16,211,702 Class A Shares exercised redemption rights. The trust account balance is approximately $13.8 million.